List Drug Candidate

BioNeex Interviews

BioNeex Interviews are part of the BioNeex vision. They provide a social media exposure to early stage biotech companies and their R&D pipelines in order to attract the right licensing and co-development partners. During the interview the interviewee, typically a biotech CEO, addresses the company’s message to potential partners, investors and other external stakeholders.
BioNeex Interview with the CEO of LIDDS, Anders Månsson

LIDDS is a Swedish drug delivery company specializing in depot formulations for intratumoral injections with its NanoZolid te

Mar 28, 2023

Cancer Therapies
Bioneex Interview with the Founder and President of AptamiR Therapeutics, Dr. Marc Thibonnier

AptamiR Therapeutics is a US based preclinical-stage biotech company developing new therapies that target fat accumulation, i

Feb 17, 2023

Cancer Therapies
BioNeex Interview with the Co-Founder CEO of Oncolyze, Dr Steven Evans

Oncolyze is a New York based preclinical-stage biotech company developing a class of therapeutics to treat cancer in a new an

Oct 17, 2022

Cancer Therapies
BioNeex Interview with CEO & Founder of Quivive Pharma, Dr. John Hsu

Quivive Pharma is a San Diego-based biotech company developing next generation opioid therapeutics to prevent opioid-induced

Jun 13, 2021

Preclinical Stage
BioNeex Interview with CEO of Blue Therapeutics, Stefan Bluemmers, MD

Blue Therapeutics is a Boston based drug discovery and development biotech company. Its disruptive R2i platform technology is

May 24, 2021